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Coronary	artery	disease	is	a	silent	
disease	process	un7l	it	progresses	to	a	
symptoma7c	stage.	According	to	the	
Na7onal	Heart,	Lung	and	Blood	
Ins7tute	(2016),	some	people	with	CAD	
show	no	signs	or	symptoms	un7l	they	
are	having	a	heart	adack,	arrhythmia,	
or	heart	failure.	Other	people	develop	
signs	and	symptoms	before	they	
develop	these	related	condi7ons.	CAD	
causes	myocardial	ischemia,	which	can	
present	as	stable	angina	or	prinzmetal	
angina.	
Signs	and	symptoms	of	myocardial	
ischemia	may	include	lel	sternal	chest	
pain,	chest	7ghtness	or	pressure,	
shortness	of	breath,	diaphoresis,	and	
pallor	(McCance	&	Huether,	2014,	
p1154).	Aler	coronary	artery	disease	
has	progressed;	heart	failure,	
arrhythmia,	and	myocardial	infarc7on	
(heart	adack)	can	cause	more	severe	
signs	and	symptoms.		
Myocardial	infarc7on	(MI)	is	a	
serious	consequence	of	advanced	CAD.	
The	signs	and	symptoms	of	a	heart	
adack	include	sudden	crushing	chest	
pain,	described	as	“an	elephant	siong	
on	my	chest”	(McCance	&	Huether,	
2014,	p1160).	
	
Coronary	artery	disease	(CAD)	is	a	
highly	prevalent	disease	in	the	United	
States	populous.	U.S.	healthcare	cost	
related	to	CAD	was	over	
$126,000,000,000	annually	in	2010.	The	
cost	is	expected	to	rise	41%	by	2040	
(Odden,	et	al.,	2011,	p	829).	CAD	is	a	
major	burden	for	the	U.S.	health	care	
system	projected	to	worsen	with	the	
aging	of	the	popula7on.		
Coronary	artery	disease	directly	
impacts	my	current	prac7ce	in	the	
Cardio-Vascular	Intensive	Care	Unit	
(CVICU).	Working	in	the	CVICU,	a	large	
percentage	of	the	pa7ent	popula7on	has	
undergone	Coronary	Artery	Bypass	
Graling	(CABG).		CABG	surgery	is	
performed	on	pa7ents	who	have	
developed	CAD.	Furthering	my	
pathological	knowledge	of	this	disease	
state	will	improve	the	quality	of	
educa7on	I	can	deliver	to	my	pa7ents.	
This	project	should	also	improve	the	
level	of	care	I	deliver	by	deepening	my	
insight	into	this	disease.		
Addi7onally,	I	have	a	strong	family	
history	of	CAD,	so	it	is	of	personal	
interest.		
	O#erbein	University,	Westerville,	Ohio 		
Listed	are	the	steps	needed	to	reduce	the	
risk	of	cardiac	events	(Pradka,	2000,	p.	
43):	
1.  smoking	cessa7on		
2.  hypertension	control	
3.  regular	physical	ac7vity		
4.  aggressive	lowering	of	elevated	low-
density	lipoprotein	(LDL)	values	
5.  losing	weight			
6.  making	healthier	dietary	choices		
A	study	by	Dmitrieva,	and	Burg	(2015),	
found	that	elevated	serum	sodium	levels,	
even	within	the	normal	range,	is	
associated	with	vascular	changes	that	
facilitate	CAD.	The	U.S.	Food	and	Drug	
Administra7on	(2016)	recommends	
2300mg	of	sodium	per	day	for	U.S.	adults	
and	1500mg	per	day	for	hypertensive	and	
pre-hypertensive	individuals.	
Medica7on	educa7on	is	another	
important	area	of	nursing	care.	Pa7ents	
need	to	understand	why	they	are	taking	
their	medica7ons,	and	the	importance	
these	medica7ons	have	in	trea7ng	their	
condi7on.	When	pa7ents	do	not	
understand	why	they	are	taking	
medica7ons,	they	are	more	likely	to	stop	
taking	them	without	consul7ng	their	
provider.	
Implica7ons	for		
Nursing	Care	
Coronary	artery	disease	is	the	result	of	
atherosclerosis	in	the	arterial	vessels	of	the	
heart.	Atherosclerosis	is	also	responsible	
for	renal	artery	stenosis,	caro7d	artery	
stenosis,	and	lower	extremity	peripheral	
artery	disease	(Imori	et	al.,	2014).	
Atherosclerosis	narrows	the	lumen	of	
arterial	vessels,	leading	to	a	decreased	
supply	of	oxygen	and	nutri7on	to	the	
myocardium.	This	depriva7on	in	blood	flow	
and	the	resul7ng	lack	of	oxygen	and	
nutrients,	leads	to	myocardial	ischemia.	If	
ischemia	is	prolonged	or	the	blood	vessel	
becomes	totally	occluded	it	can	lead	to	
acute	coronary	syndrome	(McCance	&	
Huether,	2014,	p.	1148).		
The	pathophysiological	process	of	
atherosclerosis	is	important	in	the	
development	CAD.	Listed	are	the	
pathophysiological	steps	leading	to	
atherosclerosis	as	discussed	by	McCance	
and	Huether	(2014)	on	pages	1145-1147:	
1.  Low-density	lipoprotein	(LDL)	
accumulates	within	arterial	vessel	
walls.	
2.  Injury	occurs	to	the	endothelium	of	the	
arterial	vessel	wall.	Hypertension,	
diabetes	mellitus,	smoking,	
autoimmune	response,	and	
dyslipidemia	contribute	to	this	injury.		
3.  Once	damaged,	the	endothelial	cells	
stop	producing	adequate	amounts	of	
vasodilator	and	an7thrombo7c	
cytokines.		
4.  Pro-inflammatory	cytokine	are	released	
by	damaged	endothelial	cell	allowing	
macrophage	and	leukocyte	adherence	
to	the	endothelium.		
5.  Macrophage	release	toxic	oxygen	
radicals	and	enzymes	that	result	in	
oxida7ve	stress,	causing	LDL	to	oxidize,	
further	injuring	the	vessel	wall.		
6.  Oxidized	LDL	undergo	phagocytosis	by	
macrophages	crea7ng	foam	cells.		
7.  Foam	cells	accumulate	in	the	
endothelium	crea7ng	fady	streaks.	A	
collagen	layer	forms	over	top	of	the	
fady	streaks	crea7ng	a	fibrous	plaque.		
8.  Fibrous	plaques	can	decrease	blood	
flow	causing	signs	and	symptoms	
ischemia.		
The	development	of	fibrous	plaque	is	
the	founda7on	of	atherosclerosis.	The	
majority	of	fibrous	plaques	have	the	
poten7al	to	rupture.		Pro7enases	causes	
apoptosis	within	the	fibrous	plague,	which	
leads	to	bleeding	from	the	plaque.	The	
cloong	cascade	is	ac7vated	and	a	rapid	
thrombus	forms	occluding	the	vessel.	
Plaque	rupture	is	known	as	a	complicated	
plaque.	“Other	causes	of	thrombosis	
include	plaque	erosion	which	is	less	
frequent	than	plaque	rupture	but	is	a	
common	cause	of	thrombosis	in	young	
individuals	especially	women	<50	years	of	
age”	(Sakakura	et	al.,	2013).	
	Occlusion	of	the	lumen	is	responsible	
for	many	of	the	signs	and	symptoms	
caused	by	CAD.	Calcified	plaques	are	the	
least	likely	to	rupture	and	occlude	the	
lumen.		
					Autoimmune	ideologies	for	decreased	
lumen	size	cannot	be	ruled	out.	A	study	
by	Patel,	Anzalone,	Buja,	and	Elghetany	
(2014)	found	that	Immunoglobulin	G4–
related	disease	can	result	in	fibro7c	
overgrowth	in	the	endothelium	causing	
severe	lumen	obstruc7on.	
Preven7on	of	atherosclerosis	should	
be	the	primary	goal	in	treatment	of	CAD.	
One	of	the	most	widely	used	medica7ons	
in	the	preven7on	and	treatment	of	CAD	
are	HMG-CoA	reductase	inhibitors.		
“HMG-CoA	reductase	inhibitors,	also	
known	as	sta7ns,	selec7vely	inhibit	an	
enzyme	called	HMG-CoA	reductase	(3-
hydroxy-3-methylglutaryl	coenzyme	A	
reductase)	that	is	involved	in	the	
synthesis	of	mevalonate,	a	precursor	
of	sterols	including	cholesterol.	By	
inhibi7ng	this	enzyme,	cholesterol	and	
LDL-cholesterol	produc7on	is	
decreased.	Sta7ns	also	increase	the	
number	of	LDL	receptors	on	liver	cells,	
which	enhances	the	uptake	and	
breakdown	of	LDL-cholesterol.	Most	
of	the	effects	of	sta7ns	occur	in	the	
liver.	Research	has	shown	that	
elevated	levels	of	total	cholesterol,	
LDL-cholesterol,	and	apolipoprotein	B	
are	risk	factors	for	developing	
cardiovascular	disease.”	(Anderson,	
Stewart,	Thornton,	Wilson,	Fookes,	&	
Puckey,		(Eds.).	2017).	
Apolipoprotein	B	(apoB)	levels	are	the	
best	predictor	of	fatal	myocardial	
infarc7on.	ApoB	is	a	beder	predictor	than	
LDL	at	screening	for	future	ischemic	
cardiovascular	events,	but	LDL	is	the	
current	standard	in	the	U.S.	(Benn,	
Nordestgaard,	Jensen,	&	Tybjaerg-
Hansen,	2007,	p.	661).		Decreasing	the	
circula7ng	LDL	level	forces	the	body	to	
pull	the	LDL	out	of	fibrous	plaques	in	the	
arterial	walls.	Plaque	passiva7on	is	the	
process	by	which	sta7ns	stabilize	ac7ve	
plaques	at	risk	for	rupture	(Pradka,	2000,	
p.	43).		
According	to	Bibbins-Domingo	(2016)	
“USPSTF	recommends	ini7a7ng	use	of	
low-	to	moderate-dose	sta7ns	in	adults	
aged	40	to	75	years	without	a	history	of	
CVD	who	have	1	or	more	CVD	risk	factors	
(dyslipidemia,	diabetes,	hypertension,	or	
smoking)	and	a	calculated	10-year	CVD	
event	risk	of	10%	or	greater	(B	
recommenda7on).”	While	the	benefits	of	
sta7ns	in	the	preven7on	of	CAD	has	been	
well	documented;	research	conducted	by	
Rothschild,	Novak,	and	Rich	(2016)	found	
that	sta7n	therapy	did	not	significantly	
improve	mortality	in	individuals	over	the	
age	of	80	who	were	hospitalized	with	
myocardial	infarc7on.		
	
Nausea	and	vomi7ng	can	be	caused	
from	the	pain	nerve	fibers	s7mula7ng	
the	vomi7ng	centers.	Pain	radiates	to	
the	back,	jaw,	neck,	lel	arm,	and	
shoulder.		A	feeling	of	relentless	
indiges7on	has	also	been	described	
(McCance	&	Huether,	2014,	p1160).	
The	Na7onal	Heart,	Lung	and	Blood	
Ins7tute	(2016)	list	these	signs	and	
symptoms	of	a	heart	adack:	nausea,	
vomi7ng,	light-headedness,	sleep	
problems,	fain7ng,	cold	sweats,	lack	of	
energy,	fa7gue,	and	bilateral	arm	pain.		
Many	of	the	signs	and	symptoms	of	
heart	failure	are	associated	with	the	
hearts	inability	to	pump	adequately	
and	the	associated	fluid	build	up.	The	
Na7onal	Heart,	Lung	and	Blood	
Ins7tute	(2016)	states	that	heart	
failure	leads	to	7redness,	shortness	of	
breath,	fa7gue,	trouble	breathing,	
swelling	in	the	feet,	legs,	and	stomach,	
and	neck	vein	disten7on.	
	
Retrieved	from	hdp://www.today.com/health/5-heart-
adack-warning-signs-never-ignore-t107554	
Pathophysiology	
Treatment	of	the	other	underlying	
causes	of	CAD	is	important	as	well.	
Controlling	hypertension	and	diabetes	
mellitus	are	crucial	components	in	
preven7ng	CAD.	Tobacco	cessa7on	
should	also	be	recommended.	
Surprisingly,	a	study	by	Reis	et	al.	
(2017)	found	that	Marijuana	use	is	not	
associated	with	an	increase	risk	of	CAD.	
Understanding	the	root	causes	of	CAD	
will	lead	to	beder	treatment	
recommenda7ons	from	providers.	
Unfortunately,	gene7c	tes7ng	has	not	
been	found	to	be	economically	viable	in	
detec7ng	CAD	(Hochheiser,	Juusola,	
Monane,	&	Ladapo,	2014).	Developing	
beder	tes7ng	and	treatment	op7ons	
could	mi7gate	the	future	cost	of	this	
highly	prevalent	disease.	
Retrieved	from	hdps://en.wikipedia.org/wiki/
Atherosclerosis#/media/
File:Endo_dysfunc7on_Athero.PNG	
Signs	and	Symptoms	 Conclusion	
Coronary	artery	disease	affects	
millions	of	Americans.	The	consequences	
of	untreated	CAD	can	be	detrimental	to	
ones	quality	of	life.	There	are	modifiable	
risk	factors	such	as	dyslipidemia,	
hypertension,	and	diabetes	mellitus	that	
should	be	controlled	when	possible.	
Lifestyle	changes	can	also	have	a	
significant	impact	on	the	course	of	CAD.	
As	healthcare	providers,	we	should	do	our	
best	to	minimize	the	impact	that	coronary	
artery	disease	has	on	our	pa7ent	
popula7on.	
